ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The contract research firm BioDuro has relaunched following its merger with Formex. Based in San Diego and operating mostly in China, BioDuro was acquired by PPD in 2009 but then reacquired by its founders last year. Following the merger with Formex, BioDuro now offers end-to-end drug discovery and development services, says CEO Cyrus K. Mirsaidi. Meanwhile, Frontage Laboratories has acquired two U.S. solid-dose drug plants from Sun Pharma. Frontage says the facilities will be the basis of a new contract development and manufacturing service called Frontida Biopharm.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X